Skip to Content

CD 130 (Ranitidine Hydrochloride 300 mg)

Pill with imprint CD 130 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; gerd; duodenal ulcer prophylaxis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CD 130

Ranitidine Hydrochloride

Imprint
CD 130
Strength
300 mg
Color
Brown
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, titanium dioxide, gelatin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
55111-0130 Dr. Reddy's Laboratories, Inc.
42291-0736 AvKare, Inc.

Get help with Imprint Code FAQs.

Related Images for "CD 130"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.